173 related articles for article (PubMed ID: 35610021)
1. Discovery, synthesis, and optimization of teixobactin, a novel antibiotic without detectable bacterial resistance.
Qi YK; Tang X; Wei NN; Pang CJ; Du SS; Wang K
J Pept Sci; 2022 Nov; 28(11):e3428. PubMed ID: 35610021
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and structure-activity relationships of teixobactin.
Karas JA; Chen F; Schneider-Futschik EK; Kang Z; Hussein M; Swarbrick J; Hoyer D; Giltrap AM; Payne RJ; Li J; Velkov T
Ann N Y Acad Sci; 2020 Jan; 1459(1):86-105. PubMed ID: 31792983
[TBL] [Abstract][Full Text] [Related]
3. Chemistry and Biology of Teixobactin.
Guo C; Mandalapu D; Ji X; Gao J; Zhang Q
Chemistry; 2018 Apr; 24(21):5406-5422. PubMed ID: 28991382
[TBL] [Abstract][Full Text] [Related]
4. Teixobactin, the first of a new class of antibiotics discovered by iChip technology?
Piddock LJ
J Antimicrob Chemother; 2015 Oct; 70(10):2679-80. PubMed ID: 26089440
[TBL] [Abstract][Full Text] [Related]
5. The Killing Mechanism of Teixobactin against Methicillin-Resistant Staphylococcus aureus: an Untargeted Metabolomics Study.
Hussein M; Karas JA; Schneider-Futschik EK; Chen F; Swarbrick J; Paulin OKA; Hoyer D; Baker M; Zhu Y; Li J; Velkov T
mSystems; 2020 May; 5(3):. PubMed ID: 32457238
[TBL] [Abstract][Full Text] [Related]
6. Gram-scale total synthesis of teixobactin promoting binding mode study and discovery of more potent antibiotics.
Zong Y; Fang F; Meyer KJ; Wang L; Ni Z; Gao H; Lewis K; Zhang J; Rao Y
Nat Commun; 2019 Jul; 10(1):3268. PubMed ID: 31332172
[TBL] [Abstract][Full Text] [Related]
7. Syntheses of potent teixobactin analogues against methicillin-resistant Staphylococcus aureus (MRSA) through the replacement of l-allo-enduracididine with its isosteres.
Parmar A; Iyer A; Lloyd DG; Vincent CS; Prior SH; Madder A; Taylor EJ; Singh I
Chem Commun (Camb); 2017 Jul; 53(55):7788-7791. PubMed ID: 28650495
[TBL] [Abstract][Full Text] [Related]
8. A new antibiotic kills pathogens without detectable resistance.
Ling LL; Schneider T; Peoples AJ; Spoering AL; Engels I; Conlon BP; Mueller A; Schäberle TF; Hughes DE; Epstein S; Jones M; Lazarides L; Steadman VA; Cohen DR; Felix CR; Fetterman KA; Millett WP; Nitti AG; Zullo AM; Chen C; Lewis K
Nature; 2015 Jan; 517(7535):455-9. PubMed ID: 25561178
[TBL] [Abstract][Full Text] [Related]
9. Teixobactin and Its Analogues: A New Hope in Antibiotic Discovery.
Fiers WD; Craighead M; Singh I
ACS Infect Dis; 2017 Oct; 3(10):688-690. PubMed ID: 28770988
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and application of fluorescent teixobactin analogs.
Morris MA; Jones CR; Nowick JS
Methods Enzymol; 2022; 665():233-258. PubMed ID: 35379436
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antibacterial studies of teixobactin analogues with non-isostere substitution of enduracididine.
Jin K; Po KHL; Kong WY; Lo CH; Lo CW; Lam HY; Sirinimal A; Reuven JA; Chen S; Li X
Bioorg Med Chem; 2018 Mar; 26(5):1062-1068. PubMed ID: 29398444
[TBL] [Abstract][Full Text] [Related]
12. Developing Equipotent Teixobactin Analogues against Drug-Resistant Bacteria and Discovering a Hydrophobic Interaction between Lipid II and Teixobactin.
Zong Y; Sun X; Gao H; Meyer KJ; Lewis K; Rao Y
J Med Chem; 2018 Apr; 61(8):3409-3421. PubMed ID: 29629769
[TBL] [Abstract][Full Text] [Related]
13. Teixobactin: A Paving Stone toward a New Class of Antibiotics?
Gunjal VB; Thakare R; Chopra S; Reddy DS
J Med Chem; 2020 Nov; 63(21):12171-12195. PubMed ID: 32520557
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of novel teixobactin analogues.
Schumacher CE; Harris PWR; Ding XB; Krause B; Wright TH; Cook GM; Furkert DP; Brimble MA
Org Biomol Chem; 2017 Oct; 15(41):8755-8760. PubMed ID: 28993827
[TBL] [Abstract][Full Text] [Related]
15. Teixobactin kills bacteria by a two-pronged attack on the cell envelope.
Shukla R; Lavore F; Maity S; Derks MGN; Jones CR; Vermeulen BJA; Melcrová A; Morris MA; Becker LM; Wang X; Kumar R; Medeiros-Silva J; van Beekveld RAM; Bonvin AMJJ; Lorent JH; Lelli M; Nowick JS; MacGillavry HD; Peoples AJ; Spoering AL; Ling LL; Hughes DE; Roos WH; Breukink E; Lewis K; Weingarth M
Nature; 2022 Aug; 608(7922):390-396. PubMed ID: 35922513
[TBL] [Abstract][Full Text] [Related]
16. Rational Design and Synthesis of Modified Teixobactin Analogues: In Vitro Antibacterial Activity against Staphylococcus aureus, Propionibacterium acnes and Pseudomonas aeruginosa.
Ng V; Kuehne SA; Chan WC
Chemistry; 2018 Jun; 24(36):9136-9147. PubMed ID: 29741277
[TBL] [Abstract][Full Text] [Related]
17. Defining the molecular structure of teixobactin analogues and understanding their role in antibacterial activities.
Parmar A; Prior SH; Iyer A; Vincent CS; Van Lysebetten D; Breukink E; Madder A; Taylor EJ; Singh I
Chem Commun (Camb); 2017 Feb; 53(12):2016-2019. PubMed ID: 28124045
[TBL] [Abstract][Full Text] [Related]
18. Dual Targeting of Cell Wall Precursors by Teixobactin Leads to Cell Lysis.
Homma T; Nuxoll A; Gandt AB; Ebner P; Engels I; Schneider T; Götz F; Lewis K; Conlon BP
Antimicrob Agents Chemother; 2016 Nov; 60(11):6510-6517. PubMed ID: 27550357
[TBL] [Abstract][Full Text] [Related]
19. Dissecting the Binding Interactions of Teixobactin with the Bacterial Cell-Wall Precursor Lipid II.
Chiorean S; Antwi I; Carney DW; Kotsogianni I; Giltrap AM; Alexander FM; Cochrane SA; Payne RJ; Martin NI; Henninot A; Vederas JC
Chembiochem; 2020 Mar; 21(6):789-792. PubMed ID: 31552694
[TBL] [Abstract][Full Text] [Related]
20. Total Synthesis of Teixobactin.
Giltrap AM; Dowman LJ; Nagalingam G; Ochoa JL; Linington RG; Britton WJ; Payne RJ
Org Lett; 2016 Jun; 18(11):2788-91. PubMed ID: 27191730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
